Introduction
Eurepa-V 0.5/0.2 Tablet is a drug that combines two medicine to treat type 2 diabetes. It aids in the control of high blood sugar levels in the body following each meal. When other medicine and a limited diet fail to manage abnormally high blood sugar levels, this medicine is administered.
Eurepa-V 0.5/0.2 Tablet should be taken immediately following a meal. Your doctor will determine the dosage. Do not stop taking it without first consulting your physician. If you do, your blood sugar levels may rise, putting you at risk for significant consequences such as kidney damage and blindness. Do not take the missed dose between meals if you miss a dose. Wait until your next meal and then take it as usual afterward. To make up for a missing dose, do not take a double dose. This medicine is simply one component of a comprehensive treatment plan that includes a balanced diet, regular exercise, and weight loss as directed by your doctor.
Medicine Activity
EurepaV 0.5/0.2 Tablet is a combination of repaglinide and voglibose, two anti-diabetic drugs. Repaglinide is a meglitinide analogue that causes the pancreas to release more insulin. Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown of complex carbohydrates into simple sugars like glucose in the intestine. They work together to keep blood sugar levels from increase after meals.
Related Product
Eurepa MF 2 Tablet
Eurepa-V 0.5/0.2 Tablet
Eurepa-V 0.5/0.3 Tablet
Eurepa-V 1/0.3 Tablet
Uses
Eurepa-V Tablet is used in the treatment of Type 2 diabetes mellitus
product-directions-for-use
Directions for use
Follow your doctor’s instructions on the dosage and duration of this medicine. Take it all in at once. It should not be chewed, crushed, or broken. Eurepa-V 0.5/0.2 Tablet should be consumed after a meal
Side effects
The majority of side effects are minor and will go away as your body adjusts to the medicine. If they don’t go away or you’re concerned about them, see your doctor.
Adverse effects of Eurepa-V Tablet
Flatulence
Diarrhea
Stomach pain
Hypoglycemia (low blood glucose level)
Skin rash
